For more than two decades, CHIP has been pioneering in methods and approaches for modern biosurveillance, the continuous collection and analysis of population health data for public health intelligence. We helped create the discipline of syndromic surveillance and development of one of the first web-based biosurveillance systems, AEGIS deployed to dozens of hospitals in collaboration with the Massachusetts Department of Public Health. CHIP also invented participatory surveillance and news and social media-based surveillance, and was an early innovator in postmarketing surveillance.

Projects

Publications

Beinvogl B, Palmer N, Kohane I, Nurko S. Healthcare spending and utilization for pediatric Irritable Bowel Syndrome in a commercially insured population. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2021.

Wang AL, Panganiban R, Qiu W, Kho AT, Chupp G, Meyers DA, Bleecker ER, Weiss ST, Lu Q, Tantisira KG. Drug Repurposing to Treat Glucocorticoid Resistance in Asthma. Journal of personalized medicine 2021.

Beaulieu-Jones BK, Yuan W, Brat GA, Beam AL, Weber G, Ruffin M, Kohane IS. Machine learning for patient risk stratification: standing on, or looking over, the shoulders of clinicians? NPJ digital medicine 2021.

Maharaj AS, Parker J, Hopkins JP, Gournis E, Bogoch II, Rader B, Astley CM, Ivers N, Hawkins JB, VanStone N, Tuite AR, Fisman DN, Brownstein JS, Lapointe-Shaw L. The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada. The Lancet. Infectious diseases 2021.